Merck KGaA

MRK: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€594.00DhvzjsgRmgfyxnvvd

A Narrow Moat Surrounds Merck's Diverse Life Science, Healthcare, and Electronics Portfolio

Business Strategy and Outlook

Merck KGaA has made a series of acquisitions and divestitures in the past decade or so to position the group for solid long-term growth in three key segments: life sciences, performance materials, and healthcare. However, after robust results during the pandemic due to COVID-19-related demand particularly in its life sciences business, we think the company's intermediate-term growth may soften toward more historic norms.

Sponsor Center